Eltoukhy Helmy 4

4 · Guardant Health, Inc. · Filed Jan 5, 2026

Form 4

Period: 2025-12-31

DirectorCo-Chief Executive Officer

Transactions

Exercise/Conversion
Common Stock
2025-12-31+4,815→ 2,051,958 total
Tax Payment
Common Stock
2025-12-31$102.14/sh−2,441$249,324→ 2,049,517 total
Exercise/Conversion
Common Stock
2026-01-01+23,997→ 2,073,514 total
Tax Payment
Common Stock
2026-01-01$102.14/sh−10,788$1,101,886→ 2,062,726 total
Exercise/Conversion
Restricted Stock Units
2025-12-31−4,815→ 0 total
Exercise: $0.00→ Common Stock (4,815 underlying)
Exercise/Conversion
Restricted Stock Units
2026-01-01−23,997→ 95,989 total
Exercise: $0.00→ Common Stock (23,997 underlying)

Footnotes (4)

[F1]These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability.
[F2]This represents a restricted stock unit award granted on March 12, 2025 that vests in four equal installments on the last day of each calendar quarter, March 31, 2025, June 30, 2025, September 30, 2025, and December 31, 2025.
[F3]Not applicable for Restricted Stock Units.
[F4]This represents a restricted stock unit award granted on March 18, 2024 that vests over a three-year period. 33% of the shares subject to such award vested on January 1, 2025 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter.

Documents

1 file